Literature DB >> 10532421

Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases.

K Onda1, K Wakabayashi, R Tanaka, H Takahashi.   

Abstract

We examined 26 autopsy-proven cases of intracranial malignant lymphoma (IML) in immunocompetent patients to determine the extent of neoplastic involvement of the central nervous system (CNS) and to evaluate the effects of radiation on the tumor and brain tissue. All tumors were identified as diffuse non-Hodgkin's lymphomas of B-cell origin. In six patients who had not received radiotherapy, the clinical course of the disease was short and extensive infiltration of the tumor was seen. The remaining 20 patients were treated with radiotherapy and had a longer survival time. Leptomeningeal involvement was common, but extensive subarachnoid proliferation of the tumor was seen in only two cases. The posterior, but not anterior, lobe of the pituitary was involved in 5 of 22 cases, and choroid plexus involvement was seen in 4 of 21. Direct invasion of the tumor into the spinal cord, which tended to occur in patients with posterior fossa masses, was observed in 5 of 21 cases. Following irradiation, coagulation necrosis was frequently found in the invading zone as well as in the tumor mass, and degeneration of the white matter was also seen. We suggest that IML can extensively infiltrate into the CNS, including the posterior lobe of the pituitary and spinal cord, and that radiation injury to the brain appears to occur relatively easily in this disease.

Entities:  

Mesh:

Year:  1999        PMID: 10532421     DOI: 10.1007/bf02478899

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  8 in total

1.  MRI findings of primary CNS lymphoma in 26 immunocompetent patients.

Authors:  Dong Zhang; Liang-Bo Hu; Tobias D Henning; Elisabeth M Ravarani; Li-Guang Zou; Xiao-Yuan Feng; Wen-Xian Wang; Li Wen
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

2.  A relapsed non-Hodgkin lymphoma presenting as panhypopituitarism successfully treated by chemotherapy.

Authors:  Tomas Büchler; Christelle Ferra; Nuria Virgili; Eduard Montanya; Albert Grañena
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

3.  Pituitary stalk thickening and primary central nervous system lymphoma.

Authors:  M Capra; D Wherrett; S Weitzman; P Dirks; C Hawkins; E Bouffet
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 4.  Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.

Authors:  Alexander Baraniskin; Roland Schroers
Journal:  CNS Oncol       Date:  2014-01

Review 5.  Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL.

Authors:  Alexander Baraniskin; Roland Schroers
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

6.  Primary central nervous system lymphoma with preceding spontaneous pseudotumoral demyelination in an immunocompetent adult patient: A case report and literature review.

Authors:  Junkoh Yamamoto; Shohei Shimajiri; Yoshiteru Nakano; Shigeru Nishizawa
Journal:  Oncol Lett       Date:  2014-04-04       Impact factor: 2.967

7.  Apparent diffusion coefficient value for a B-cell central nervous system lymphoma in a cat.

Authors:  Toshiyuki Tanaka; Hideo Akiyoshi; Hitoshi Shimazaki; Ryo Kawakami; Keiichiro Mie; Yuki Yamada; Fumihito Ohashi
Journal:  JFMS Open Rep       Date:  2018-01-23

8.  Primary Pituitary Lymphoma in Immunocompetent Patients: A Report on Two Case Studies and the Review of Literature.

Authors:  Lian Duan; Jie Liu; Yan Zhang; Lijia Cui; Xiao Zhai; Boju Pan; Lin Lu; Hui Pan; Yong Yao; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-04       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.